Lazard Asset Management
KRMD icon

Lazard Asset Management’s KORU Medical Systems KRMD Stock Holding History

Lazard Asset Management’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,659
Closed -$59K – 2083
2025
Q2 		$59K Buy
+16,659
New +$47.3K ﹤0.01% 1974
2021
Q1 		– Sell
-5,687
Closed -$34K – 1939
2020
Q4 		$34K Buy
+5,687
New +$31.8K ﹤0.01% 1518

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's KRMD Position: Q3 2025 in Review

Lazard Asset Management sold out of KORU Medical Systems (KRMD) in Q3 2025, closing a stake of 16,659 shares — an estimated $59K sold.

Lazard Asset Management first reported a position in KRMD in Q4 2020 and held it in 2 quarters. The position peaked at $59K in Q2 2025. 76 funds tracked by Wall St. Rank hold KRMD as of Q3 2025.

  • Lazard Asset Management reported no remaining KORU Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 16,659 KORU Medical Systems shares in Q3 2025, an estimated $59K.
  • Lazard Asset Management first reported a position in KORU Medical Systems in Q4 2020 and held it in 2 quarters.
  • Lazard Asset Management's KORU Medical Systems position peaked at $59K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.